We use cookies to ensure the correct functioning of this website, provide the best possible service to you, enhance your user experience, and optimize our website. Find out more about how we use cookies and how you can change your settings.
Fresenius Kabi Oncology Limited, a wholly owned subsidiary of Fresenius Kabi, is a leading player in oncology generics segment based on the strength of its comprehensive product portfolio of injectables, oral, cytotoxics, cytostatics, intermediates and Active Pharmaceutical Ingredients (APIs).
With the generic oncology products portfolio, Fresenius Kabi Oncology Limited offers an integrated approach to cancer therapy. Globally, this includes I.V. solutions and drugs, devices, parenteral and enteral nutrition, compounding services and home care. Our competitively priced portfolio of generic I.V. and oral formulations compliments our existing range of oncology products and services.
FRESENIUS KABI ONCOLOGY LIMITED
Plot No. 11, Sector-32 Echelon Institutional Area Gurugram-122001 Haryana, India. Ph : +91 124 4885000 / 3325000 Fax : +91 124 4885003
B-310, Som Datt Chambers-1 Bhikaji Cama Place, New Delhi- 110066, India. Ph : +91-11-26105570 Fax : + 91-11-26195965